Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

NCT06420089

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Columbia University Irving Medical Center New York, United States

University of Pennsylvania - Abramson Caner Center Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT05943496

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions: B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Augusta Cancer Center Augusta, Georgia, United States

View Trial Details

Recruiting

Tissue Repository: CTCL Collection Protocol

NCT02840747

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

NCT03595917

Conditions: B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Burkitt Lymphoma, +27 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Recruiting

Auto Stem Cell Transplant for Lymphoma Patients

NCT03125642

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +18 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

NCT04496349

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: MD Anderson Houston, Texas, United States

View Trial Details

Recruiting

Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

NCT07025005

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Damanhur Oncology Center Damanhur, El- Behira, Egypt

Tanta University Tanta, El-Gharbya, Egypt

View Trial Details

Recruiting

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

NCT07002216

Conditions: Advanced Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +8 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

NCT06128070

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions